Choi, Kee-Hyun 2024-01-20T12:00:50Z 2024-01-20T12:00:50Z 2021-09-05 2013-08 1746-0441 https://pubs.kist.re.kr/handle/201004/127816 Introduction: Neuronal T-type calcium channels (T-type channels) are expressed throughout the central nervous system (CNS), regulating neuronal excitability. T-type channels in the CNS are involved in various neurophysiological and pathophysiological states, and thus have become a promising therapeutic target. Areas covered: This article discusses T-type channel-related CNS disorders such as epilepsy, neuropathic pain, insomnia and tremor disorders including Parkinson's disease. In addition, the article reviews T-type channel inhibitors showing efficacy in animal models in such CNS disorders, with a focus on classical T-type channel inhibitors with limited specificity for T-type channels as well as novel inhibitors with high specificity. Furthermore, the article also presents and discusses the next generation of T-type channel inhibitor discovery, virtual as well as screening and high-throughput screening techniques. Expert opinion: Although T-type channel-related CNS disorders seem to be diverse, it converges into the one major cause - abnormal hyperactivity of neurons. T-type channel-specific inhibitors could thus be commonly applied for the treatment of such CNS disorders regardless of the complexity of individual disorder. Structural information of inhibitor-binding sites would facilitate the discovery of the next generation of T-type channel-specific inhibitors by stimulating structure-based rational drug designs. English INFORMA HEALTHCARE RAT SENSORY NEURONS 5-ALPHA-REDUCED NEUROACTIVE STEROIDS CHILDHOOD ABSENCE EPILEPSY CA2+ CHANNELS IN-VITRO THALAMIC NEURONS ESSENTIAL TREMOR UP-REGULATION PARKINSONS-DISEASE NEUROPATHIC PAIN The design and discovery of T-type calcium channel inhibitors for the treatment of central nervous system disorders Article 10.1517/17460441.2013.796926 1 EXPERT OPINION ON DRUG DISCOVERY, v.8, no.8, pp.919 - 931 EXPERT OPINION ON DRUG DISCOVERY 8 8 919 931 scie scopus 000322078000002 2-s2.0-84880752150 Pharmacology & Pharmacy Pharmacology & Pharmacy Review RAT SENSORY NEURONS 5-ALPHA-REDUCED NEUROACTIVE STEROIDS CHILDHOOD ABSENCE EPILEPSY CA2+ CHANNELS IN-VITRO THALAMIC NEURONS ESSENTIAL TREMOR UP-REGULATION PARKINSONS-DISEASE NEUROPATHIC PAIN calcium channel inhibitors central nervous system disorders rational drug design T-type calcium channels